Patents by Inventor Birte Aggeler

Birte Aggeler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using
    Patent number: 11897958
    Abstract: Described herein are monoclonal antibodies that bind to VSIG-4 including antibodies that block the binding of VSIG-4 to SIGLEC-7, compositions including the monoclonal antibodies, and methods of making and using those antibodies and compositions.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: February 13, 2024
    Assignee: BIO-TECHNE CORPORATION
    Inventors: Birte Aggeler, Christine Goetz, Jody Bonnevier, Christopher Carlin Valley, Christopher Hammerbeck, Ernesto Ruben Resnik
  • Compounds that modulate the interaction of VISTA and VSIG3 and methods of making and using
    Patent number: 11787857
    Abstract: Described herein are polyclonal and monoclonal antibodies that binds to VSIG3, compounds that modulate the interaction of VISTA and VSIG3, and methods of making and using the polyclonal and monoclonal antibodies and compounds. Also described herein are methods that include modulating the interaction of VISTA and VSIG3 by introducing a compound that modulates the interaction of VISTA and SIG3.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: October 17, 2023
    Assignee: BIO-TECHNE CORPORATION
    Inventors: Christine Goetz, Christopher Hammerbeck, Christopher Valley, Jody Bonnevier, Birte Aggeler, Jinghua Wang, Guoping Wu, Vassilios Kalabokis, Jose Fernando Bazan
  • HYBRIDOMA CLONES, MONOCLONAL ANTIBODIES TO VSIG-4, AND METHODS OF MAKING AND USING
    Publication number: 20210087276
    Abstract: Described herein are monoclonal antibodies that bind to VSIG-4 including antibodies that block the binding of VSIG-4 to SIGLEC-7, compositions including the monoclonal antibodies, and methods of making and using those antibodies and compositions.
    Type: Application
    Filed: August 19, 2020
    Publication date: March 25, 2021
    Inventors: Birte Aggeler, Christine Goetz, Jody Bonnevier, Christopher Carlin Valley, Christopher Hammerbeck, Ernesto Ruben Resnik
  • COMPOUNDS THAT MODULATE THE INTERACTION OF VISTA AND VSIG3 AND METHODS OF MAKING AND USING
    Publication number: 20200362031
    Abstract: Described herein are polyclonal and monoclonal antibodies that binds to VSIG3, compounds that modulate the interaction of VISTA and VSIG3, and methods of making and using the polyclonal and monoclonal antibodies and compounds. Also described herein are methods that include modulating the interaction of VISTA and VSIG3 by introducing a compound that modulates the interaction of VISTA and SIG3.
    Type: Application
    Filed: February 1, 2019
    Publication date: November 19, 2020
    Inventors: Christine Goetz, Christopher Hammerbeck, Christopher Valley, Jody Bonnevier, Birte Aggeler, Jinghua Wang, Guoping Wu, Vassilios Kalabokis, Jose Fernando Bazan
  • Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using
    Patent number: 10752689
    Abstract: Described herein are monoclonal antibodies that bind to VSIG-4 including antibodies that block the binding of VSIG-4 to SIGLEC-7, compositions including the monoclonal antibodies, and methods of making and using those antibodies and compositions.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: August 25, 2020
    Assignee: BIO-TECHNE CORPORATION
    Inventors: Birte Aggeler, Christine Goetz, Jody Bonnevier, Christopher Carlin Valley, Chris Hammerbeck, Ernesto Ruben Resnik
  • HYBRIDOMA CLONES, MONOCLONAL ANTIBODIES TO VSIG-4, AND METHODS OF MAKING AND USING
    Publication number: 20180371095
    Abstract: Described herein are monoclonal antibodies that bind to VSIG-4 including antibodies that block the binding of VSIG-4 to SIGLEC-7, compositions including the monoclonal antibodies, and methods of making and using those antibodies and compositions.
    Type: Application
    Filed: June 26, 2018
    Publication date: December 27, 2018
    Inventors: Birte Aggeler, Christine Goetz, Jody Bonnevier, Christopher Carlin Valley, Chris Hammerbeck